Abstract
AbstractOsteoarthritis causes pain and functional disability for over 500 million people worldwide. To develop disease-stratifying tools and modifying therapies, we need a better understanding of the molecular basis of the disease in relevant tissue and cell types. Here, we study primary cartilage and synovium from 115 patients with osteoarthritis to construct a deep molecular signature map of the disease. By integrating genetics with transcriptomics and proteomics, we discover molecular trait loci in each tissue type and omics level, identify likely effector genes for osteoarthritis-associated genetic signals and highlight high-value targets for drug development and repurposing. These findings provide insights into disease aetiopathology, and offer translational opportunities in response to the global clinical challenge of osteoarthritis.
Funder
Medical Research Council Centre for Integrated Research into Musculoskeletal Ageing grant
Versus Arthritis; Tissue Engineering and Regenerative Therapies Centre
Wellcome Trust
EC | Horizon 2020 Framework Programme
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference69 articles.
1. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1204–1222 (2020).
2. Murphy, L. et al. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum. 59, 1207–1213 (2008).
3. Murphy, L. B. et al. One in four people may develop symptomatic hip osteoarthritis in his or her lifetime. Osteoarthr. Cartil. 18, 1372–1379 (2010).
4. Murphy, L. B., Cisternas, M. G., Pasta, D. J., Helmick, C. G. & Yelin, E. H. Medical expenditures and earnings losses among US dults with arthritis in 2013. Arthritis Care Res. 70, 869–876 (2018).
5. Torio, C. M. & Moore, B. J. Statistical Brief #204. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013. (Agency for Healthcare Research and Quality, 2016).
Cited by
64 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献